dpp-4 inhibitors and glp-1 agonists together Clinical Use of do not combine dpp-4 inhibitors

There is no required waiting period between your injection and your blood donation

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

both are tools that may help individuals achieve their health goals, but neither can necessarily solve their respective health conditions for everyone (Srinivasan et al., 2025)

There is no coaching, nutrition program, or fitness layer

You'll receive your treatment in a professional, comfortable environment, with our team always available to answer questions and cheer you on

The Verdict: May offer supportive benefits for metabolism and satiety, but not a strong or direct GLP-1 booster